Intensity Therapeutics INTS
NASDAQ INTS
$3.38 -0.05 (-1.31%)
As of: Sep 30, 2026 · 2:44 PM EDT

Intensity Therapeutics (INTS) Change in Interest Receivables (2023 - 2024)

Updated

Intensity Therapeutics (INTS) recorded Change in Interest Receivables of $134,000 in FY2024, down 32.0% from $197,000 in FY2023.

Analysis

Intensity Therapeutics (INTS) Change in Interest Receivables (2023 - 2024) Analysis & Trends

  • Per Business Quant data, INTS's Change in Interest Receivables was $197,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Interest Receivables (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Intensity Therapeutics 10.01 Mn 10.01 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 17,000.00
Jun 30, 2024 38,000.00
Mar 31, 2024 79,000.00
Dec 31, 2023 86,000.00
Sep 30, 2023 111,000.00
API Access

Intensity Therapeutics Change in Interest Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-interest-receivables&ticker=INTS&period=max&api_key=YOUR_API_KEY